Luton and Dunstable University Hospital is an acute hospital in Luton, Bedfordshire, England, run by Bedfordshire Hospitals NHS Foundation Trust. It provides medical and surgical services for over 350,000 people in southern Bedfordshire, the north of Hertfordshire and parts of Buckinghamshire.

There are 660 (2019) beds in Luton and Dunstable Hospital.

During the past decade, Luton and Dunstable Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 6 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Luton and Dunstable Hospital" #1 sponsor was "University College, London" with 5 trials, followed by "University Hospital Southampton NHS Foundation Trust" with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "University Hospitals of Derby and Burton NHS Foundation Trust" with 2 trials sponsored and "University of Edinburgh" with 2 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Luton and Dunstable Hospital" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "King's College London" with 2 trials as a collaborator, "NHS Lothian" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator and "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Luton and Dunstable Hospital" are "Breast Cancer" (6 trials), "Prostate Cancer" (4 trials), "Atrial Fibrillation" (3 trials), "Diffuse Large B Cell Lymphoma" (3 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Luton and Dunstable Hospital" in a lesser frequency.

Most popular intervention types in "Luton and Dunstable Hospital" are "Drug" (27 trials), "Procedure" (10 trials), "Other" (8 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Cyclophosphamide" (2 trials), "Prednisolone" (2 trials), "Rituximab" (2 trials) and "Vincristine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Luton and Dunstable Hospital" are 39 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Luton and Dunstable Hospital". undefined are not yet recruiting, 15 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Luton and Dunstable Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Luton and Dunstable Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".